Search alternatives:
significant we » significant i.e (Expand Search), significant _ (Expand Search), significant i (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), nn decrease (Expand Search)
Showing 1 - 20 results of 122,014 for search '(( significantly associated diseases ) OR ( significant we decrease ))', query time: 1.01s Refine Results
  1. 1
    In individuals affected by PCA, there is a significant downregulation of genes associated with the cholesterol biosynthetic pathway.

    In individuals affected by PCA, there is a significant downregulation of genes associated with the cholesterol biosynthetic pathway. by Leemon Nikhila (22250736)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 2
    Significance of the association of infectious diseases with EBF and other associated factors.

    Significance of the association of infectious diseases with EBF and other associated factors. by Faruq Abdulla (8061062)

    Published 2022
    “…<p>Significance of the association of infectious diseases with EBF and other associated factors.…”
    Save to List
    Saved in:
  3. 3
    Pathway associated with decreased inflammation.

    Pathway associated with decreased inflammation. by Monica N. Mweetwa (17054522)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  4. 4
    Table2_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.DOCX

    Table2_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.DOCX by Sofia Schaeffer (20379954)

    Published 2024
    “…<p>Metabolic dysfunction–associated steatotic liver disease (MASLD) is a multisystemic disease with a multifactorial pathogenesis involving dietary, environmental, and genetic factors. …”
    Save to List
    Saved in:
  5. 5
    Table1_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.DOCX

    Table1_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.DOCX by Sofia Schaeffer (20379954)

    Published 2024
    “…<p>Metabolic dysfunction–associated steatotic liver disease (MASLD) is a multisystemic disease with a multifactorial pathogenesis involving dietary, environmental, and genetic factors. …”
    Save to List
    Saved in:
  6. 6
    Summary statistics from significant disease associations.

    Summary statistics from significant disease associations. by Margaret Sunitha Selvaraj (13994016)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  7. 7
    DataSheet1_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF

    DataSheet1_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF by Sofia Schaeffer (20379954)

    Published 2024
    “…<p>Metabolic dysfunction–associated steatotic liver disease (MASLD) is a multisystemic disease with a multifactorial pathogenesis involving dietary, environmental, and genetic factors. …”
    Save to List
    Saved in:
  8. 8
    DataSheet3_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF

    DataSheet3_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF by Sofia Schaeffer (20379954)

    Published 2024
    “…<p>Metabolic dysfunction–associated steatotic liver disease (MASLD) is a multisystemic disease with a multifactorial pathogenesis involving dietary, environmental, and genetic factors. …”
    Save to List
    Saved in:
  9. 9
    DataSheet2_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF

    DataSheet2_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF by Sofia Schaeffer (20379954)

    Published 2024
    “…<p>Metabolic dysfunction–associated steatotic liver disease (MASLD) is a multisystemic disease with a multifactorial pathogenesis involving dietary, environmental, and genetic factors. …”
    Save to List
    Saved in:
  10. 10
    DataSheet4_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF

    DataSheet4_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF by Sofia Schaeffer (20379954)

    Published 2024
    “…<p>Metabolic dysfunction–associated steatotic liver disease (MASLD) is a multisystemic disease with a multifactorial pathogenesis involving dietary, environmental, and genetic factors. …”
    Save to List
    Saved in:
  11. 11
    Some of the significant disease-pathways associated with COVID-19.

    Some of the significant disease-pathways associated with COVID-19. by Mahnaz Habibi (11204536)

    Published 2021
    Save to List
    Saved in:
  12. 12
    Significant disease phenotypes with LADA loci.

    Significant disease phenotypes with LADA loci. by Margaret Sunitha Selvaraj (13994016)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  13. 13
    SNPs in autophagy genes with the most significant association with cardiometabolic traits and diseases.

    SNPs in autophagy genes with the most significant association with cardiometabolic traits and diseases. by Eliana Portilla-Fernandez (6504227)

    Published 2019
    “…<p>SNPs in autophagy genes with the most significant association with cardiometabolic traits and diseases.…”
    Save to List
    Saved in:
  14. 14
    Genome-wide significant GWAS variants of complex eye diseases and traits.

    Genome-wide significant GWAS variants of complex eye diseases and traits. by Tobias Strunz (737315)

    Published 2020
    Save to List
    Saved in:
  15. 15
    Significant factors associated with prevalent fractures in patients with chronic liver disease.

    Significant factors associated with prevalent fractures in patients with chronic liver disease. by Chisato Saeki (8193192)

    Published 2021
    “…<p>Significant factors associated with prevalent fractures in patients with chronic liver disease.…”
    Save to List
    Saved in:
  16. 16
    Significant associations from basic model—Epigenome-wide association studies on incident disease states.

    Significant associations from basic model—Epigenome-wide association studies on incident disease states. by Robert F. Hillary (7879010)

    Published 2023
    “…<p>Significant associations from basic model—Epigenome-wide association studies on incident disease states.…”
    Save to List
    Saved in:
  17. 17
    Significant associations from basic model—Epigenome-wide association studies on prevalent disease states.

    Significant associations from basic model—Epigenome-wide association studies on prevalent disease states. by Robert F. Hillary (7879010)

    Published 2023
    “…<p>Significant associations from basic model—Epigenome-wide association studies on prevalent disease states.…”
    Save to List
    Saved in:
  18. 18
    Significant associations from fully adjusted model—Epigenome-wide association studies on incident disease states.

    Significant associations from fully adjusted model—Epigenome-wide association studies on incident disease states. by Robert F. Hillary (7879010)

    Published 2023
    “…<p>Significant associations from fully adjusted model—Epigenome-wide association studies on incident disease states.…”
    Save to List
    Saved in:
  19. 19
    Significant associations from fully adjusted model—Epigenome-wide association studies on prevalent disease states.

    Significant associations from fully adjusted model—Epigenome-wide association studies on prevalent disease states. by Robert F. Hillary (7879010)

    Published 2023
    “…<p>Significant associations from fully adjusted model—Epigenome-wide association studies on prevalent disease states.…”
    Save to List
    Saved in:
  20. 20
    iKIR score decreases protection associated with protective class II genotypes in T1D.

    iKIR score decreases protection associated with protective class II genotypes in T1D. by Laura Mora-Bitria (20477525)

    Published 2024
    Save to List
    Saved in:

Search Tools: